Cardiogen

Cardiogen (tetrapeptide Ala-Glu-Asp-Gly) is a synthetic short peptide bioregulator from the Khavinson series, originally developed from research on cardiac tissue extracts. Like other members of this peptide bioregulator class, it represents a four-amino acid sequence proposed to have tissue-specific gene-regulatory effects when introduced to cardiomyocytes.

Research on Cardiogen has investigated its potential to influence cardiomyocyte gene expression profiles, support cardiac tissue maintenance, and provide cardioprotective effects in models of age-related cardiac decline. Studies have examined changes in cardiac biomarkers, cardiomyocyte survival, and functional parameters in aging animal models, positioning it within the broader context of peptide bioregulator research for age-related organ function maintenance.

• Cardiomyocyte gene expression and short peptide bioregulator pharmacology
• Cardiac tissue protection and age-related cardiac decline models
• Cardiomyocyte survival and cardiac biomarker studies
• Short peptide gene-regulatory mechanism research (Khavinson series)
• Longevity and cardiovascular health maintenance research
• Comparison with other organ-specific peptide bioregulators

Dose levels referenced by the MVLabs peptide calculator, shown for research reference only:

Peptide bioregulator studied in short 10-day cycles.

Research reference only — not dosing guidance for human use. Use the calculator for other vials or volumes.

Supplied as a lyophilized powder. Store at 2–8 °C on receipt; protect from heat, light and moisture, and avoid excessive agitation. If reconstitution is required for laboratory work, use sterile technique — bacteriostatic water, or 0.6% acetic acid for low-solubility peptides. Protocols vary by research application.